Related Experiment Video
Updated: Aug 9, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
BRAF and MEK mutations make a late entrance
Nick Duesbery1, George Vande Woude
1Van Andel Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA. nick.duesbery@vai.org
Science'S STKE : Signal Transduction Knowledge Environment
|March 30, 2006
Summary
Germline mutations in KRAS, BRAF, and MEK1/2 genes, previously thought to cause embryonic death, are surprisingly linked to cardio-facio-cutaneous (CFC) syndrome, revealing their role in human development.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- KRAS, BRAF, and MEK1/2 are key signaling partners in the MAPK pathway.
- These proteins are crucial for embryonic development and implicated in tumor progression when dysregulated.
Purpose of the Study:
- To investigate the unexpected association between germline mutations in KRAS, BRAF, and MEK1/2 genes and developmental syndromes.
- To understand the role of these genes in human development beyond their known functions.
Main Methods:
- Analysis of germline mutations in KRAS, BRAF, and MEK1/2 genes.
- Clinical evaluation of patients with cardio-facio-cutaneous (CFC) syndrome.
Main Results:
- Germline mutations in KRAS, BRAF, and MEK1/2 genes are associated with cardio-facio-cutaneous (CFC) syndrome.
- Contrary to expectations, these mutations do not lead to embryonic lethality but cause specific developmental abnormalities.
Conclusions:
- Germline mutations in KRAS, BRAF, and MEK1/2 can cause specific developmental syndromes like CFC syndrome.
- This finding opens new avenues for research into the developmental roles of these proteins and their involvement in cancer.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...